Sipuleucel T

Sipuleucel T Struktur
917381-47-6
CAS-Nr.
917381-47-6
Englisch Name:
Sipuleucel T
Synonyma:
Sipuleucel T
CBNumber:
CB82658203
Summenformel:
Molgewicht:
0
MOL-Datei:
Mol file

Sipuleucel T Eigenschaften

Sicherheit

Sipuleucel T Chemische Eigenschaften,Einsatz,Produktion Methoden

Beschreibung

Sipuleucel-T is the first FDA-approved therapeutic cancer vaccine. It is approved for the treatment of asymptomatic or minimally symptomatic metastatic castration-resistant (hormone-refractory) prostate cancer. Sipuleucel-T is described as a therapy rather than a precisely defined therapeutic agent because it is an autologous vaccine that is generated from each individual patient's own blood cells.

Originator

Dendreon (United States)

Trademarks

Provenge

Sipuleucel T Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte


Sipuleucel T Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
NCE Biomedical Co.,Ltd. 4000-027-021 |24 +86-13986109188 | +86-15623472865 | +81-08033611988
China 1494 55
China Nobel Chem Co., Limited +86(0)21 60484900
China 764 50
SPIRO PHARMA
eric_feng1954@126.com China 9254 55
Pushan Industry (Shaanxi) Co., Ltd. 029-81310890 13571859809
info@pushanshiye.com China 9999 58

  • Sipuleucel T
  • 917381-47-6
Copyright 2019 © ChemicalBook. All rights reserved